Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays from Prostate Cancer Update

Genitourinary Cancers — 5-Minute Journal Club Issue 2 with Professor Thomas Powles: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

22 minutes Posted Jun 5, 2026 at 10:00 pm.

Circulating tumor DNA (ctDNA) analyses with adjuvant nivolumab for MIBC in the CheckMate 274 study

Use of ctDNA to guide response-adapted bladder preservation for patients with MIBC

ctDNA response-adapted treatment de-escalation for patients with metastatic urothelial carcinoma: The CT-READ trial

Emerging data and studies regarding urinary tumor DNA

0:00

22:38

Download MP3

Share at current time

Show notes

Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer.

CME information and select publications

← See all 66 episodes of Prostate Cancer Update